Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 70

1.

Does Mood Disorder Questionnaire identify sub-threshold bipolarity? Evidence studying worsening of quality of life.

Carta MG, Norcini-Pala A, Moro MF, Balestrieri M, Caraci F, Dell'Osso L, Sciascio GD, Faravelli C, Hardoy MC, Aguglia E, Roncone R, Nardi AE, Drago F.

J Affect Disord. 2015 May 11;183:173-178. doi: 10.1016/j.jad.2015.04.058. [Epub ahead of print]

PMID:
26021966
2.

The attributable burden of panic disorder in the impairment of quality of life in a national survey in Italy.

Carta MG, Moro MF, Aguglia E, Balestrieri M, Caraci F, Dell'Osso L, Di Sciascio G, Drago F, Hardoy MC, D'Aloja E, Machado S, Roncone R, Faravelli C.

Int J Soc Psychiatry. 2015 Mar 12. pii: 0020764015573848. [Epub ahead of print]

PMID:
25770204
3.

Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam.

Leggio GM, Torrisi SA, Castorina A, Platania CB, Impellizzeri AA, Fidilio A, Caraci F, Bucolo C, Drago F, Salomone S.

Eur Neuropsychopharmacol. 2014 Nov 15. pii: S0924-977X(14)00301-0. doi: 10.1016/j.euroneuro.2014.11.004. [Epub ahead of print]

PMID:
25482686
4.

Eating disorders as a public health issue: prevalence and attributable impairment of quality of life in an Italian community sample.

Carta MG, Preti A, Moro MF, Aguglia E, Balestrieri M, Caraci F, Dell'Osso L, Di Sciascio G, Drago F, Faravelli C, Hardoy MC, D'Aloja E, Cossu G, Calò S, Palumbo G, Bhugra D.

Int Rev Psychiatry. 2014 Aug;26(4):486-92. doi: 10.3109/09540261.2014.927753.

PMID:
25137115
5.

Levels of the Rab GDP dissociation inhibitor (GDI) are altered in the prenatal restrain stress mouse model of schizophrenia and are differentially regulated by the mGlu2/3 receptor agonists, LY379268 and LY354740.

Orlando R, Borro M, Motolese M, Molinaro G, Scaccianoce S, Caruso A, di Nuzzo L, Caraci F, Matrisciano F, Pittaluga A, Mairesse J, Simmaco M, Nisticò R, Monn JA, Nicoletti F.

Neuropharmacology. 2014 Nov;86:133-44. doi: 10.1016/j.neuropharm.2014.07.009. Epub 2014 Jul 22.

PMID:
25063582
6.

Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial.

Malaguarnera G, Pennisi M, Gagliano C, Vacante M, Malaguarnera M, Salomone S, Drago F, Bertino G, Caraci F, Nunnari G, Malaguarnera M.

Hepat Mon. 2014 May 5;14(5):e11608. doi: 10.5812/hepatmon.11608. eCollection 2014 May.

7.

Homocysteine serum levels in diabetic patients with non proliferative, proliferative and without retinopathy.

Malaguarnera G, Gagliano C, Giordano M, Salomone S, Vacante M, Bucolo C, Caraci F, Reibaldi M, Drago F, Avitabile T, Motta M.

Biomed Res Int. 2014;2014:191497. doi: 10.1155/2014/191497. Epub 2014 Apr 28.

8.

Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials.

Grosso G, Pajak A, Marventano S, Castellano S, Galvano F, Bucolo C, Drago F, Caraci F.

PLoS One. 2014 May 7;9(5):e96905. doi: 10.1371/journal.pone.0096905. eCollection 2014.

9.

Omega-3 fatty acids and depression: scientific evidence and biological mechanisms.

Grosso G, Galvano F, Marventano S, Malaguarnera M, Bucolo C, Drago F, Caraci F.

Oxid Med Cell Longev. 2014;2014:313570. doi: 10.1155/2014/313570. Epub 2014 Mar 18. Review.

10.

Comparing factor structure of the Mood Disorder Questionnaire (MDQ): In Italy sexual behavior is euphoric but in Asia mysterious and forbidden.

Carta MG, Massidda D, Moro MF, Aguglia E, Balestrieri M, Caraci F, Dell'Osso L, Di Sciascio G, Drago F, Faravelli C, Hardoy MC, Calò S, Pollice R, Fortezzo A, Akiskal H.

J Affect Disord. 2014 Feb;155:96-103. doi: 10.1016/j.jad.2013.10.030. Epub 2013 Oct 31.

PMID:
24238869
11.

Role of the Transforming-Growth-Factor-β1 Gene in Late-Onset Alzheimer's Disease: Implications for the Treatment.

Bosco P, Ferri R, Salluzzo MG, Castellano S, Signorelli M, Nicoletti F, Nuovo SD, Drago F, Caraci F.

Curr Genomics. 2013 Apr;14(2):147-56. doi: 10.2174/1389202911314020007.

12.

Searching for disease-modifying drugs in AD: can we combine neuropsychological tools with biological markers?

Caraci F, Castellano S, Salomone S, Drago F, Bosco P, Di Nuovo S.

CNS Neurol Disord Drug Targets. 2014 Feb;13(1):173-86. Review.

PMID:
24040795
13.

Pericentrin expression in Down's syndrome.

Salemi M, Barone C, Romano C, Salluzzo R, Caraci F, Cantarella RA, Salluzzo MG, Drago F, Romano C, Bosco P.

Neurol Sci. 2013 Nov;34(11):2023-5. doi: 10.1007/s10072-013-1529-z. Epub 2013 Aug 27.

PMID:
23979692
14.

Clinical pharmacology of novel anti-Alzheimer disease modifying medications.

Caraci F, Bosco P, Leggio GM, Malaguarnera M, Drago F, Bucolo C, Salomone S.

Curr Top Med Chem. 2013;13(15):1853-63. Review.

PMID:
23931438
15.

Dopamine D(3) receptor as a new pharmacological target for the treatment of depression.

Leggio GM, Salomone S, Bucolo C, Platania C, Micale V, Caraci F, Drago F.

Eur J Pharmacol. 2013 Nov 5;719(1-3):25-33. doi: 10.1016/j.ejphar.2013.07.022. Epub 2013 Jul 18. Review.

PMID:
23872400
16.

Metal fume fever.

Malaguarnera M, Drago F, Malaguarnera G, Li Volti G, Salomone S, Caraci F, Galvano F, Vacante M, Bucolo C, Malaguarnera M.

Lancet. 2013 Jun 29;381(9885):2298. doi: 10.1016/S0140-6736(13)60689-3. No abstract available.

PMID:
23809563
17.

New definition of addiction proposed by the American Society of Addiction Medicine: which implications for the treatment of tobacco dependence?

Caraci F, Drago F.

Eur Neuropsychopharmacol. 2014 Jan;24(1):1-4. doi: 10.1016/j.euroneuro.2013.05.003. Epub 2013 Jun 16. No abstract available.

PMID:
23778079
18.

Quality of life and urban / rural living: preliminary results of a community survey in Italy.

Carta MG, Aguglia E, Caraci F, Dell'Osso L, Di Sciascio G, Drago F, Del Giudice E, Faravelli C, Hardoy MC, Lecca ME, Moro MF, Calò S, Casacchia M, Angermeyer M, Balestrieri M.

Clin Pract Epidemiol Ment Health. 2012;8:169-74. doi: 10.2174/1745017901208010169. Epub 2012 Nov 30. Erratum in: Clin Pract Epidemiol Ment Health. 2013;9:148. Dell'osso, Liliana [corrected to Dell'Osso, Liliana]; Sciascio, Guido Di [corrected to Di Sciascio, Guido]; Giudice, Emilio Del [corrected to Del Giudice, Emilio].

19.

Fingolimod protects cultured cortical neurons against excitotoxic death.

Di Menna L, Molinaro G, Di Nuzzo L, Riozzi B, Zappulla C, Pozzilli C, Turrini R, Caraci F, Copani A, Battaglia G, Nicoletti F, Bruno V.

Pharmacol Res. 2013 Jan;67(1):1-9. doi: 10.1016/j.phrs.2012.10.004. Epub 2012 Oct 13.

PMID:
23073075
20.

Epigenetic drugs for Alzheimer's disease: hopes and challenges.

Caraci F, Leggio GM, Drago F, Salomone S.

Br J Clin Pharmacol. 2013 Apr;75(4):1154-5. doi: 10.1111/j.1365-2125.2012.04443.x. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk